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ABSTRACT. This paper provides an analysis of 
the attitudes and activities of UK medical research 
charities in relation to open access (OA). Both 
quantitative and qualitative data are presented derived 
from a recent survey of charities covering areas 
such as policy development, funding arrangements, 
and business process design for OA. Positions on 
key issues including green and gold OA, funding 
article-processing charges (APCs), and publication 
licences are assessed. Modelling of potential APCs 
as a percentage of overall annual research spend 
is undertaken to show possible costs of a charged-
for gold system. Medical research charities clearly 
regard OA as important and some see it as an 
opportunity to further their mission. However, many 
expressed signiﬁ cant concerns particularly about the 
costs and expertise required to support OA. Further 
co-ordination of policy development and action across 
the sector and with other stakeholders is recommended 
in order to help ensure optimal implementation of OA.
Introduction
Medical research funders, including chari-
ties, were amongst some of the earliest advo-
cates and adopters of open access (OA). In 
the USA, the National Institutes of Health 
(NIH), and in the UK, the Wellcome Trust, 
were active in the OA debate as early as 2002. 
NIH launched a formal OA policy in 2004 and 
Wellcome in 2005, both requiring their grant-
holders to make their research outputs openly 
accessible. The publicly funded Medical 
Research Council (MRC) in the UK fol-
lowed with an OA policy in 2006, and several 
UK charities introduced policies soon after: 
Arthritis Research UK, Cancer Research UK, 
and the Myrovlytis Trust all introduced OA 
policies in 2007. These developments served 
to create and reinforce the strong association 
between medical research funders and OA. 
However, much of the commentary to date on 
the particular relationship between charities in 
the medical research area and OA has tended 
to focus on speciﬁ c organizations which have 
been prominent in public discussions, such as 
Wellcome. The positions of a wide range of 
charity organizations within the sector have 
not been systematically investigated. This 
research study aims to go some way to cor-
recting that by providing a current view of the 
sector-wide situation in the UK.
This is particularly relevant at present. The 
last two years have witnessed some major OA 
developments which between them are likely 
to bring OA into the mainstream of research 
publishing and dissemination for many dis-
ciplines – developments to which medical 
research charities need to respond. In the UK, 
the publication of the Finch Report (in June 
2012),1 followed by new OA-related policies 
from Research Councils UK (in July 2012 
and revised in March 2013),2 and the Higher 
Education Funding Council for England (pub-
lished as an initial statement in July 2012 and 
then a consultation in February 2013),3 are all 
highly signiﬁ cant developments. In Europe, © Stephen Pinﬁ eld 2013 Stephen Pinﬁ eld
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other countries are also moving ahead with 
new OA policies, and at a Europe-wide level, 
the European Commission adopted a new OA 
policy in July 2012.4 In the USA, the Federal 
Fair Access to Science and Technology 
Research (FASTR) bill was announced in 
February 2013, and the Ofﬁ ce of Science and 
Technology Policy (OSTP) also published its 
OA policy memorandum the same month.5 
Elsewhere, the Australian Research Council 
introduced a new OA policy in January 2013.6 
These and similar developments have created 
a climate in which medical research charities 
are developing and reviewing their own posi-
tions and policies.
In the context of these developments, 
the research reported here was designed to 
investigate the attitudes and activities of UK 
medical research charities and other related 
medical research funders in relation to OA, 
speciﬁ cally:
1. To enable a better understanding of the 
current landscape of medical research char-
ities and related organizations and their 
attitudes to OA in order to inform policy 
discussions
2. To capture data in key areas of activity, 
including current funding levels, numbers 
of research outputs, and article-processing 
charges (APC) payment levels, in order to 
understand the current situation
3. To surface major concerns charities cur-
rently have with OA, and their views on 
opportunities OA creates, and how these 
relate to their mission and affect their 
donors and beneﬁ ciaries
4. To identify actions which may address cur-
rent concerns and exploit opportunities, 
and recommend how these might be imple-
mented by key players
The research was overseen by a Stakeholder 
Group consisting of representatives from the 
Association of Medical Research Charities 
(AMRC) and Europe PubMed Central 
(Europe PMC) whose members were the tar-
get group for the research. The AMRC is a 
UK membership organization consisting of 
124 medical and health research charities 
with an organizational mission ‘to support 
the sector’s effectiveness and advance medi-
cal research by developing best practice, pro-
viding information and guidance, improving 
public dialogue about research and science, 
and inﬂ uencing government’.7 Its members 
include trusts, funding their work from invest-
ments or endowments, and fund-raising bod-
ies, which raise money from donations. The 
size of the organizations varies, from those 
reporting expenditure on medical research 
as low as £10,000 per year to as high as over 
£500 million. A number of AMRC members 
are also funders of Europe PMC. Europe PMC 
is the European implementation of the larger 
PubMedCentral repository containing high-
quality biomedical resources, including pub-
lished research outputs. When this research 
was undertaken, Europe PMC had 17 UK 
funders, 13 of whom are also members of the 
AMRC. The small number of UK organiza-
tions in Europe PMC who are not members 
of AMRC are government-sponsored agencies 
rather than charities.
Literature review
The case for open access has often been made 
in terms of potential medical beneﬁ ts.8 This 
view clearly informed the developments of 
medical research funders. For example, in one 
of its early policy documents, NIH refers to 
the potential for an ‘acceleration of medical 
cures’ created by OA.9 Subsequent qualita-
tive work carried out to test this hypothesis 
on behalf of NIH has shown positive results,10 
although obtaining clear quantitative results 
on this may be challenging.
Whilst this view may have underpinned a 
number of OA policy implementations, the 
thinking of funders has not been widely doc-
umented except in the case of a small num-
ber of large funders. For example, Terry,11 
Pinﬁ eld,12 and Walport and Kiley13 have 
described the position of the Wellcome Trust 
at various times. In their 2006 paper, Walport 
and Kiley as Director of the Wellcome Trust 
and Head of eStrategy, respectively, outline a 
number of issues which feature in the research 
reported here. Initially, they highlight some 
of the circumstances which gave rise to the 
Trust’s OA policy including an exercise which 
showed that only 6% of articles reporting 
Wellcome-funded research were freely avail-
able on the Web. They then summarize the 
Wellcome policy which came into effect in 
October 2006 requiring authors to make their 
the AMRC 
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charities
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papers freely available via PubMed Central. 
They specify a number of beneﬁ ts their pol-
icy is expected to deliver, including increas-
ing opportunities for researchers’ work to be 
more widely read and cited, enabling linking 
and integration of resources (e.g. linking pub-
lications with chemical compound databases), 
helping funding bodies to evaluate research, 
and facilitating the preservation of research. 
They describe their preference for ‘gold’ OA 
(OA publication in journals), including the 
business model involving payment of APCs. 
Developments such as these have contributed 
to the growth of gold OA in particular in bio-
medicine.14 Were the Trust to fund all papers 
which cite the Wellcome as a funder, Walport 
and Kiley estimate it would cost around 1.5% 
of their total research spend, although with 
the funding of many research projects shared 
with other funders, this percentage would be 
expected to fall as others adopt OA policies. 
As well as funding APCs, they also describe 
the Wellcome’s investment in creating a ver-
sion of PubMed Central in the UK, a service 
which in its expanded form, Europe PMC, 
has now been supported by a number of other 
funders in the biomedical ﬁ eld.
Other charities have made their OA poli-
cies publicly available on their websites, 
many of which also require deposit in Europe 
PMC. Many allow ‘green’ OA (the depositing 
of versions of papers in OA repositories) as 
well as gold, although the emphasis given to 
each varies. For example, Arthritis Research 
UK includes on its website a step-by-step 
guide for authors describing various ways in 
which its grant-holders can make their papers 
OA.15 The guide describes the organiza-
tion’s requirement for papers to be made OA 
within six months of publication on Europe 
PMC, how authors can if appropriate ‘self-
archive’ in Europe PMC, and how the charity 
will support the payment of APCs in certain 
circumstances.
Whilst a number of organizations have 
released similar policies, there is little pub-
lished literature describing their thinking or 
attitudes to OA. Some of this can be gar-
nered from other sources, however, includ-
ing evidence recently submitted to various 
UK Parliamentary investigations of open 
access. In its written evidence to the House 
of Commons Select Committee on Business, 
Innovation and Skills, for example, Cancer 
Research UK stated: ‘Cancer Research UK 
supports the goals of open access (OA) as we 
believe that making the results of research 
widely and freely available can only beneﬁ t 
the research effort and the economy.’16 The 
organization signalled its preference for the 
gold route but questioned whether charities 
should pay APCs. It stated that payments of 
APCs should be covered as an indirect cost of 
research along with other infrastructure and 
overhead costs rather than as part of direct 
research grants. In the UK, indirect costs for 
charity-funded research are paid by govern-
ment via the Charity Research Support Fund.
Submitting evidence to the same Select 
Committee enquiry, the Wellcome Trust also 
commented on the important issue of the level 
of openness associated with OA as deﬁ ned in 
licences. It stated its support for the use of the 
CC-BY (Creative Commons attribution) pub-
lication licence which allows the unrestricted 
reuse of material: ‘Our move to require CC-BY 
licence ﬂ ows from our ﬁ rm belief that the full 
research and economic beneﬁ t of published 
research will only be realised when there are 
no restrictions on access to, and re-use of, 
this information.’17 It quoted the example of 
text mining which may not always be permit-
ted even for OA content under certain more 
restrictive licence conditions.
These and other key issues have, of 
course, been widely discussed and debated 
in the general OA literature and other fora. 
Organizations like the Wellcome have contrib-
uted to this wider debate, including commis-
sioning early research on the potential costs of 
an OA research communication system18 and 
more recent work modelling costs of different 
approaches to OA.19
Research design
The research reported here was designed to 
address a number of key issues arising from 
the literature as well as current practice. It 
was aimed at members of AMRC and Europe 
PMC who were asked to respond on behalf of 
their organizations, and took the form of an 
online questionnaire divided into a number of 
sections covering:
• organizational policies in relation to OA;
the research 
reported here 
was designed 
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number of key 
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• attitudes to various approaches to the 
implementation of OA;
• funding arrangements for OA;
• challenges, opportunities and concerns cre-
ated by OA.
The questionnaire consisted of a total of 21 
questions, although not all questions were 
designed to be answered by all respondents 
because of routing between questions depen-
dent on previous responses. The questionnaire 
comprised a combination of closed questions 
intended to produce quantitative data on 
speciﬁ c issues, and open questions designed 
to generate qualitative data from free-text 
comments. Mandatory questions were kept 
to a minimum in order to encourage as many 
responses as possible.
Following ethics approval granted as part of 
the University of Shefﬁ eld research ethics pro-
cess, the questionnaire was piloted between 6 
and 11 March 2013. Piloting led to a number 
of amendments being made to the question-
naire to improve clarity and to ensure that it 
took only between 10 and 20 minutes to com-
plete (depending on the extent to which free-
text comments were added by respondents) in 
order to maximize responses. The ﬁ nal version 
of the questionnaire was made publicly avail-
able between 12 March and 16 April 2013. 
Invitations to participate were distributed by 
email by AMRC and Europe PMC to their 
members. These included an initial invitation 
on 12 March 2013, followed by a reminder on 
25 March 2013.
Findings
Fifty-six responses to the survey were received. 
These included 50 complete responses plus 
6 incomplete responses but which included 
usable data. Of the 56 responses, 14 were 
from Europe PMC members, 12 of them from 
the UK (11 also being AMRC members). 
The two non-UK responses were eliminated 
from the analysis in order to create a coher-
ent UK-speciﬁ c results set. However, the one 
UK non-AMRC response was included in the 
analysis since it came from a closely allied 
organization. There were, therefore, a total of 
54 usable responses to the questionnaire as a 
whole, although because of routing between 
questions and the low number of mandatory 
questions, the number of responses for each 
question varied.
OA policies
In response to the question, ‘Does your orga-
nization currently have a policy of encourag-
ing or requiring grant-holders to make their 
research outputs open access?’, 19 of the 54 
respondents (35%) reported that they did. A 
further 19 responded, ‘No – but one is likely to 
be introduced in the next 12 months’, whilst 
14 (26%) did not have a policy and reported 
that ‘one is not likely to be introduced in the 
next 12 months’ (Figure 1). Seventy per cent 
of respondents therefore either had a policy 
already in place or expected to introduce one 
in the next year.
The 19 respondents with a policy gave 
details of when it came into effect, with 
dates ranging from 2006 to 2013 (Figure 2). 
The position is, however, a ﬂ uid one. Several 
respondents stated their organizations were 
likely to review their current policy in the 
light of recent developments. Other organiza-
tions commented they were monitoring devel-
opments and considering their position.
46 respondents provided ﬁ gures for their 
annual research spend (see below), mostly in 
the form of approximate ﬁ gures for 2011–12. 
Comparing these with the responses to the 
question on OA policy, there was a strong 
positive relationship between large organiza-
tions (by research spend) and those with an 
OA policy. 68% of organizations reporting a 
research spend of over £1.5 million per year 
had a policy in place, compared with 22% 
below £1.5 million (χ2 = 10.797; degrees of 
freedom = 2; P =0.0045). All Europe PMC 
members who responded had an OA policy (a 
condition of Europe PMC membership) com-
pared with 17% of non-Europe PMC members.
Whilst the details of these policies differed 
between organizations, most of them shared 
two key features in common. Sixteen of the 
19 policies speciﬁ ed that outputs should be 
made available in an open access form within 
six months of publication, and 15 speciﬁ ed 
they should be deposited in Europe PMC (or 
PubMed Central). The remainder did not 
specify any allowable embargo or deposition 
venue.
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Compliance
Of the 19 respondents with OA policies who 
commented on the monitoring and measur-
ing compliance of grant holders, eight (42%) 
stated they did measure compliance whilst 
nine (47%) did not (two did not know). 
Those that did measure compliance were able 
to choose from a variety of suggested ways 
in which they checked compliance or specify 
other approaches. The most popular of these 
(both used by ﬁ ve) were checking compli-
ance of articles listed in PubMed and checking 
Europe PMC. However, only a small number 
of respondents were able to state speciﬁ c lev-
els of compliance, and in those cases mostly 
estimates were given with ﬁ gures commonly 
between 20% and 40%. One organization 
with an established OA policy quoted ﬁ gures 
as high as 65–70%, and another organization 
with the new policy reported full compliance 
but over a very short period.
Some respondents stated that that policy 
had only recently come into effect and it was 
therefore too early to measure compliance. 
Other respondents stated that they had only 
recently begun to monitor compliance or were 
planning to do so in the near future. However, 
resources were reported to be a major con-
straint, with one respondent commenting:
‘Currently [the organization] does not have 
the in-house resource to measure compli-
ance, but it is something we are keen and 
plan to do over the coming year, should 
resources allow it.’
Of the 19 respondents with an OA policy, 
10 (53%) stated that their organization 
undertook ‘actions to improve compliance’ 
with their OA policy. A wide variety of dif-
ferent methods were used, mostly focused 
on awareness-raising and encouragement of 
authors. For example, eight respondents stated 
they wrote to authors to encourage them to 
comply. Other awareness-raising approaches 
mentioned included outlining the OA policy 
in grant application documents and remind-
ing grant-holders in routine correspondence. 
However, fewer respondents favoured using 
sanctions, with only a small number of orga-
nizations stating they were willing to with-
hold funding in various ways from researchers 
or their organizations in order to encourage 
compliance. However, resources were again 
reported to be a concern:
‘We could, in principle, do any or all of 
the other actions listed [in the survey] to 
improve compliance. However we do not 
have the resources (research advice and 
administrative team time, and budget) 
which would be necessary to provide sup-
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Figure 3. ‘Which of the following does your 
organization’s policy allow?’ (n = 19).
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Figure 1. ‘Does your organization currently have 
a policy encouraging or requiring grant-holders 
to make their research outputs open access?’ 
(n = 54).
$





	
%
$$	 $$% $$& $$ $$ $ $ $  

!
Figure 2. ‘When did your organization’s policy 
come into effect?’ (n = 19).
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port of this kind for all of the publications 
resulting from the research we fund.’
There is then considerable variation in 
whether and how charities are monitoring 
compliance with their OA policies and the 
extent to which they are taking action to 
improve compliance levels.
Green or gold OA?
Most of the OA policies of respondents 
allowed either ‘green’ or ‘gold’ OA. Of the 19 
respondents replying to this question in the 
survey, 16 allowed green and 12 gold OA, with 
most allowing both (Figure 3). Five respon-
dents stated they allowed green but not gold, 
whilst only one reported allowing gold but 
not green. Four stated a preference for gold 
and one for green, whilst seven had no stated 
preference. One respondent commented that 
allowing both made it easier for grant-holders 
to comply with their policy.
A number of different reasons were cited 
for preferring gold, including immediate OA 
availability of content, support for a work-
ing business model and deposition in Europe 
PMC:
‘We prefer gold open access as it means the 
research is immediately available upon pub-
lication, and it also helps transition to and 
support a more transparent business model 
for publishers. However, allowing green 
access as an option provides more ﬂ exibil-
ity and maximizes the number of journals 
an author may choose to publish in whilst 
remaining compliant with our policy.’
However, even where gold was preferred, con-
cern was expressed regarding resources:
‘Gold would be our ideal and we want all 
grant holders to aspire to this. However, 
complexity of enforcing this and current 
uncertainty about how it would be funded 
makes it an impractical policy to enforce.’
‘In order to promote only gold access, we 
would need to consider the cost implica-
tions, as we estimated it would cost [the 
organization] around £300k p.a. – a cost 
that is currently not budgeted.’
The resource issue was mentioned by some as 
a reason for preferring green:
‘Green open access requires no costs for 
making the content open access … it does 
not restrict the journal that the researcher 
publishes in but allows for the content to 
become open access and available to all. 
Researchers are free to follow the gold path 
should they choose to do so, but at their 
own cost.’
One organization stated that their thinking 
on green-gold balance may be reviewed in the 
light of recent UK developments (such as the 
RCUK policy) which gave greater prominence 
to Gold:
‘The matter was last discussed by our 
[research committee] in 2007. At the time 
it was assumed that the green route to OA 
would be the most prevalent. Given the 
more recent prominence of gold, we may 
need to revisit our original policy.’
Publication licences
Only one organization said it speciﬁ ed particu-
lar licences for its grant-holders to use: either 
the Creative Commons Attribution licence 
(CC-BY) or Creative Commons Attribution 
Non-Commercial licence (CC-BY-NC). One 
organization said it was introducing a licence 
condition (CC-BY) in the near future where 
it had funded an APC. Another organization 
said it did not specify a particular licence but 
did require content to be reusable. However, 
the majority of respondents said they did not 
specify a particular licence, several comment-
ing that there was little awareness of licensing 
issues in the organization, for example: ‘We do 
not understand enough about this issue yet to 
introduce it into our policy at this stage.’
One respondent commented that they did 
not see it as the funder’s responsibility:
‘We provide no guidance on this matter, in 
our view this is a matter for the author and 
their employing institution.’
The level of engagement from charities on this 
issue is then currently low.
Publishing costs
On the issue of publishing costs, 30 (60%) of 
the 50 respondents who answered the ques-
tion either opted for ‘strongly agree’ or ‘tend 
to agree’ with the statement of principle that 
there is then 
considerable 
variation in 
whether and 
how charities 
are monitoring 
compliance 
with their OA 
policies
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‘the cost of publishing is a cost of research’. 
Five (10%) disagreed, either tending to dis-
agree or strongly disagreeing (Figure 4).
One respondent summarized the most com-
mon view:
‘The dissemination of research ﬁ ndings can 
reasonably be viewed as the ﬁ nal stage in 
a research project – and if there is a cost 
associated with this, as there often is, I 
would err on the side of considering this a 
legitimate research cost.’
A number of respondents commented on the 
importance of publishing research results: 
‘The expectation of funders and the duty of 
researchers that the research should be pub-
lished. Not much point otherwise!’
However, some respondents made the point 
that there is an argument charities should 
not necessarily pay costs of OA publishing, 
deﬁ ning them as indirect costs (overheads 
and infrastructure) rather than direct costs of 
the research itself. Several made this point in 
detail, for example:
‘Peer-reviewed publications are a vital 
part of research and offer a ﬁ lter through 
which quality research can be identiﬁ ed. 
Managing such a process understandably 
incurs a cost. Traditionally the costs of 
publishing were supported by library sub-
scriptions funded by government. With the 
trend towards gold open access increased 
costs for government are likely to be off-
set by a reduction in library subscriptions. 
However, charity funders of research would 
experience the increase in costs, with no 
offset. As a fundraising charity we see a 
distinction between the direct costs of 
research which we can support, in line with 
our charitable objectives, and the indirect 
costs which we do not. This distinction is 
already acknowledged by the government 
and we feel that the costs of publishing 
should fall into the latter category.’
On the speciﬁ c question of whether OA pub-
lishing costs should be considered a direct or 
indirect cost of research, 17 of the 49 (34%) 
who answered the question agreed that APCs 
should be considered part of indirect costs, 
with only ﬁ ve (10%) disagreeing. However, 
there was considerable uncertainty, with 18 
(37%) opting for, ‘neither agree nor disagree’ 
and nine (18%), ‘Do not know/not applicable’. 
While some respondents (supporting the view 
expressed above) stated directly that, ‘publica-
tion should be seen as an infrastructure cost’, 
and therefore not covered by charity funders, 
this was not a universal view. One respondent 
summarized the contrary view: ‘APC’s are 
clearly a direct cost of doing research, research 
without publication is of limited value.’
Others expressed a more pragmatic view:
‘I think an argument could be made either 
way on this one. It would be hard to see it 
as an indirect cost as it is due to a direct 
output of the research, however, smaller 
Charities will struggle to pay this.’
‘… the fact is someone has to pay …’
This is clearly an area of ongoing debate with 
signiﬁ cant practical implications. Successive 
UK governments have supported the Charity 
Research Support Fund providing money 
directly to universities to compensate for the 
‘lost’ indirect costs arising from charity-funded 
grants. The question of whether the costs of 
OA publishing should be seen as part of this is 
obviously an important one with major ﬁ nan-
cial consequences. The new RCUK policy of 
providing block grants to institutions to pay 
APCs, reversing their previous approach of 
allowing for payment through direct research 
grants, has perhaps served to heighten debate 
on this issue.
Funding APCs
Respondents were very nearly evenly split 
Figure 4. ‘To what extent does your organization 
agree or disagree with the statement “the cost of 
publishing is a cost of research”’? (n = 50).
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on whether or not their organization funded 
APCs: 23 of the 49 respondents (47%) stated 
they did by choosing at least one of the afﬁ r-
mative options (Figure 5); 25 (51%) stated 
they did not fund APCs, and one did not 
know.
Of the 49 respondents, those organizations 
with an OA policy were more likely to fund 
APCs (χ2 = 10.379; degrees of freedom = 2; 
P = 0.0056). 14 of the 19 (74%) of the organi-
zations with an OA policy stated they funded 
APCs, whereas only 9 of the 30 without a pol-
icy (30%) did. Also, large organizations were 
more likely than smaller organizations to fund 
APCs (χ2 = 8.091; degrees of freedom = 1; 
P = 0.0044). Of the 19 organizations with a 
research spend of more than £1.5 million per 
year, 14 (74%) funded APCs, whereas only 8 
of the 27 (30%) with a research spend below 
£1.5 million did.
Of those funding APCs, 16 allowed 
researchers to apply for additional fund-
ing, 9 allowed use of direct research grants, 
and 1 provided researchers’ institutions with 
block grants. Five organizations reported they 
funded APCs in more than one way. There 
was, however, signiﬁ cant variation in how 
well-established these arrangements were and 
how they were handled. Some respondents 
reported having established policies and pro-
cesses allowing them to fund APCs routinely:
‘Publication costs are an allowable cost for 
grants. We see no difference between these 
costs and requests for funds to attend con-
ferences to present posters or deliver an 
oral presentation.’
Others allowed one-off applications for sup-
port, although often operating on a small 
scale: ‘There is a very limited fund and there 
has to be exceptional circumstances for the 
fund to be applied.’
Some took a pragmatic approach allow-
ing the use of research underspends to fund 
APCs:
‘We do not provide a separate fund for 
APCs, but researchers can utilize under-
spend should they so choose. We have no 
provision for papers arising form awards 
that have ﬁ nished.’
Several respondents mentioned that they 
rationed expenditure, often at rates below 
most current APC levels:
‘At the moment publication costs (of any 
type) are requested by some applicants (not 
all) but we limit the amount we fund to 
£1,000 per grant.’
‘All grants are awarded a APC contribution 
on a sliding scale. Grants under £50k get 
£1k, £50-100k get £2k and over £100k get 
£3k.’
Resource constraints were the major reason 
cited for not funding APCs:
‘We simply do not have the budget to do 
this at this time. We do agree with open 
access publishing but our budget is very 
small as it is and the priority at the present 
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Figure 5. ‘Does your organization provide funds to pay article-processing charges (APCs) to make journal 
articles open access?’ (n = 49, allowing selection of more than one option under ‘Yes’).
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time has been to keep our research grants 
scheme going.’
Some organizations, however, reported that 
they had not yet been asked to fund APCs, 
with others reporting that they were at various 
stages of reviewing or changing their position:
‘[O]ur board have just approved a new 
open access policy that will come into 
force in the autumn. We will be off-setting 
APCs for gold OA and will earmark a sepa-
rate budget, outside the grants, to do this. 
Grant-holders will have to apply for APC 
funding on a case by case basis.’
The payment of APCs to grant holders is then 
an issue for which there is signiﬁ cant variation 
and change in the sector at present.
Cost data
With concerns about resourcing OA publish-
ing and dissemination prominent in many 
comments of respondents, the issue of fund-
ing, and particularly the expected proportion 
of APCs of overall research spend, is partic-
ularly relevant. Respondents were asked to 
provide ﬁ gures on their organization’s overall 
annual research spend (ARS) and the num-
ber of papers published resulting from funded 
research in order to provide data for cost 
modelling. 26 organizations provided (in most 
cases, approximate) data in both areas (ARS 
and published outputs), 22 from 2011–12 and 
4 from 2010–11. From these data it was pos-
sible to model the proportion of ARS which 
would be needed to fund APCs in the hypo-
thetical event that all outputs were made OA 
via the charged-for gold route. Modelling was 
carried out using three possible APC levels:
• £2,072 (£1,727 plus VAT): the APC level 
used by RCUK in allocating block grants to 
UK higher education institutions;20
• £1,800 (£1,500 plus VAT): based on Kiley’s 
estimates;21
• £1,327 (including VAT): the mean average 
APC level actually paid by the University 
of Nottingham for non-BioMedCentral 
publications reported by Pinﬁ eld and 
Middleton.22
Calculations are presented in Table 1. The 
data show signiﬁ cant variation, with percent-
ages as low as 0.5% to as high as 11.2% for an 
APC of £2,072. Percentage ﬁ gures, however, 
do not seem to follow any pattern relating to 
ARS, although the highest ﬁ gures do occur 
where ARS is £1 million or below (where 
small changes in numbers of published papers 
can have a signiﬁ cant impact on percentages).
These data are presented in a ‘box plot’ to 
illustrate both the distribution and cluster-
ing of data points (Figure 6). The ‘whisker’ 
lines extending from the boxes represent the 
full data range and the boxes themselves the 
middle 50% of the data points, with the top 
of each box being the 75th percentile and the 
bottom of each box the 25th percentile. These 
show a clustering of data points between 1.4% 
and 4.6% depending on the APC level. The 
median value for each series is possibly most 
signiﬁ cant with a data range such as this and 
is represented by the line in each box (50th 
percentile). The median values are:
• 3.7% of ARS for an APC of £2,072;
• 3.2% of ARS for an APC of £1,800;
• 2.4% of ARS for an APC of £1,327.
These data then provide a preliminary view of 
the proportion of annual research spend that 
would be required to support the charged-for 
gold OA route. The presentation of the data 
is, of course, provisional. Figures provided are 
estimates and more precise and consistent 
data gathering would be required to produce 
more deﬁ nitive results. Also, additional fac-
tors need to be taken into account. One of 
these is the possibility of double counting as a 
result of joint funding of research.
A signiﬁ cant proportion of research funded 
by medical research charities is co-funded 





	
	

	



	

	

	

Figure 6. Article-processing charges as a 
percentage of overall annual research spend at 
different APC levels.
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by more than one organization. Walport and 
Kiley, in their description of Wellcome policy, 
stated that ‘more than 80% of papers that 
acknowledged our support also acknowledge 
the support of one or more other funders’.13 
Because of this it is possible that at least some 
APC payments could be shared between co-
funders, thus reducing the overall percentage 
of ARS for each. In order to assess how sig-
niﬁ cant this factor may be, an investigation 
was carried out focusing on research papers 
housed in Europe PMC and citing funding 
from at least one of the eight original Europe 
PMC funders for whom detailed metadata are 
present in Europe PMC (Table 2). For these 
papers, co-funding with at least one of the 
other seven organizations was checked for the 
period 1 January 2012–31 December 2012.
A total of 17,760 papers were produced in 
2012 which included acknowledgements to 
one of these eight funders, with 7,661 (43.1%) 
co-funded by at least one other of the eight. 
Table 1. Article-processing charges as a percentage of overall annual research spend at different APC 
levels
2011–12 Annual 
research spend (£)a
2011–12 published 
articlesa
APC at £1,727 plus 
VAT (£2,072) (%)
APC at £1,500 plus 
VAT (£1,800) (%)
APC at £1,327 incl 
VAT (%)
643,000,000 4,433 1.4 1.2 0.9
332,000,000 1,800 1.1 1.0 0.7
210,500,000b 1,434b 1.4 1.2 0.9
28,000,000 292 2.2 1.9 1.4
10,000,000 192 4.0 3.5 2.5
6,000,000 172 5.9 5.2 3.8
5,039,040 50–75 2.1–3.1 1.8–2.7 1.3–2.0
5,000,000 76 3.1 2.7 2.0
4,800,000b 86b 3.7 3.2 2.4
4,062,012 43 2.2 1.9 1.4
2,700,000 60 4.6 4.0 2.9
1,800,000 40 4.6 4.0 2.9
1,400,000 10 1.5 1.3 0.9
1,300,000 25 4.0 3.5 2.6
1,030,000 16 3.2 2.8 2.1
1,000,000 31 6.4 5.6 4.1
800,000b 2b 0.5 0.5 0.3
737,000 40 11.2 9.8 7.2
449,000b 8b 3.7 3.2 2.4
424,334 8 3.9 3.4 2.5
250,000 3 2.5 2.2 1.6
235,000 3 2.6 2.3 1.7
200,000 10 10.4 9.0 6.6
155,193 3 4.0 3.5 2.6
140,000 5 7.4 6.4 4.7
136,725 2 3.0 2.6 1.9
aMost ﬁ gures are estimates.
b2010–11 data.
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The implications of this for APC payments are 
potentially signiﬁ cant. For example, if all of 
these papers were funded by just two funders 
and they shared the cost equally, the eight 
funders would expect to pay the full costs of 
56.9% of papers they fund but half the cost 
of the remaining 43.1%. This means they 
would be paying three-quarters of what the 
cost would be if each funder paid the full cost 
for every paper they funded. This would lead 
to a signiﬁ cant reduction in APC payments 
for each funder and thus a reduction in the 
percentage of ARS required for APCs. This 
analysis indicates then that the issue of double 
counting is potentially serious. However, it 
remains unclear how this may impact on the 
wider range of funders and articles reported in 
this paper. Clearly, more work is required in 
this area.
Opportunities and challenges
Respondents were invited to identify major 
positive and negative impacts on them asso-
ciated with recent OA developments. On 
the positive side, recent developments were 
reported to have raised the proﬁ le of OA, 
encouraging charities to develop and promote 
clear policy positions:
‘We are aware that this is something it is 
essential for us to have a policy on and are 
developing one.’
‘We were planning to implement an open 
access policy (and fund) regardless of exter-
nal developments. However, the fact that 
this is becoming more widely accepted as 
the direction of travel makes it easier to 
implement.’
Some respondents expressed enthusiastic sup-
port for OA and believed recent developments 
would help to further OA:
‘We are passionate about Open Access 
and approve of a discussion surrounding it, 
which in effect supports our pre-existing 
policies.’
‘Recent OA developments have been 
welcomed by [the organization], as it has 
raised the issue of OA with a wider group 
of people and will ultimately increase the 
number of research publications available 
to the public, and the number of organiza-
tions engaging positively with the issue.’
A number of organizations expressed optimis-
tic views that OA was likely to improve access 
to the outputs of the research they funded:
‘Increased access to the results of our 
research which should hopefully increase 
its reach and impact.’
‘It makes [the organization’s] funded 
re search available and more accessible.’
Other positive impacts mentioned included 
reducing the overall costs of dissemination of 
research outputs, encouraging greater trans-
parency in research, allowing the charity to 
access publications it itself has funded, and 
Table 2. Co-funded research articles in Europe PubMed Central for 2012 by the eight founding members 
of Europe PMC
Funder Total no. of papers No. of co-funded 
papers
% of papers co-funded 
by at least one of the 
other seven funders
Arthritis Research UK 321 115 35.8
Biotechnology and Biological Sciences 
Research Council
3,131 1,004 32.1
British Heart Foundation 1,140 596 52.3
Cancer Research UK 1,616 688 42.6
Chief Scientiﬁ c Ofﬁ cer 207 102 49.3
Department of Health 1,009 483 47.9
Medical Research Council 4,849 2,393 49.4
Welcome Trust 5,487 2,280 41.6
Total 17,760 7,661 43.1
recent 
developments 
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raising the proﬁ le of the charity itself and its 
work.
However, some organizations had not 
yet seen any impacts of recent OA develop-
ments but in some cases reported being better 
informed:
‘We have not really addressed this matter in 
detail. It is to be discussed during 2013/14 
ﬁ nancial year.’
‘No impact as yet but increases our willing-
ness to use the open access route.’
The major negative impacts raised related to 
resources and ﬁ nancial impacts. Some of these 
related to the speciﬁ c issue of funding APCs:
‘Supporting OA means funding APCs, 
which could be a signiﬁ cant cost and ulti-
mately reduce the number of grants we can 
award.’
‘Will increase our costs for publication, 
which must come from a ﬁ xed overall 
research budget.’
Other concerns about resourcing included 
increased administrative costs associated with 
supporting OA, monitoring compliance and 
communicating with researchers. In particular, 
a number of respondents expressed concerns 
about confusion and negativity within the 
research community:
‘Potential confusion within the research 
community (one paper, 6 authors, multiple 
funders, multiple open access policies …).’
‘The reception of some of these develop-
ments by some parts of the research com-
munity has not always been positive. We 
are happy to have concerns be brought 
to light so that they can be discussed and 
addressed, but the beneﬁ ts of OA can be 
lost in the detail of these discussions which 
is unfortunate as the beneﬁ ts are so great.’
Concern was also expressed about increased 
costs in relation to the expectations of donors 
and other stakeholders:
‘As a charitable research funder reliant on 
public donations, our aims are to fund the 
best quality research in our ﬁ eld and to pro-
vide real improvements to the lives of peo-
ple with [particular medical] conditions. 
The current trend towards gold open access, 
and the potential of increased cost of open 
access to the charity is a cause of concern. 
As a fundraising charity, we must operate 
in line with our charitable objectives, and 
meet donor’s expectations that their contri-
butions are spent directly on research; pay-
ing article processing charges (APCs) may 
not align with this expectation.’
Expertise and further assistance
Participants were asked whether their orga-
nization had ‘the expertise and resources to 
advise researchers on open access issues’. Of 
the 47 answering this question, the majority 
(26 or 55%) believed they did not have the 
expertise and resources required, whereas 
only 16 (34%) believed they did. There was 
an observable correlation between large orga-
nizations and those stating they had sufﬁ cient 
expertise. However, because of the small sam-
ple size this could not be tested statistically. 
Nevertheless, as a number of free-text com-
ments also mentioned the constraints felt by 
small organizations, the issue of organizational 
size may reasonably be judged to be a factor.
Given the expressed deﬁ ciencies in exper-
tise and resources, 33 respondents made a 
wide range of suggestions regarding what fur-
ther assistance could be given to charities, 
particularly by AMRC. 22 of these comments 
highlighted the need for more information 
and advice on OA issues. Respondents were 
keen to receive information on key issues and 
wanted opportunities to share best practice. 
Others speciﬁ cally requested guidance and 
training, including recommendations on pol-
icy and implementation issues from AMRC. 
A number of comments also suggested pos-
sible co-ordination of OA policy development 
amongst charities to create greater evenness 
across the sector. To inform this, some respon-
dents also suggested that more work be car-
ried out on developing a clear evidence base 
about OA and its impact on medical research 
charities. In addition, it was suggested, a single 
point of information about publishers licensing 
policies would be useful, possibly involving the 
augmentation of existing SHERPA RoMEO 
services (as has already been done in the past 
for the Wellcome Trust and RCUK).23 Some 
respondents went further and suggested pos-
sible co-ordinated action by charities in areas 
other concerns 
about 
resourcing 
included 
increased 
administrative 
costs associated 
with supporting 
OA
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such as sharing administrative costs, including 
shared processes and systems, and negotiating 
with publishers over licensing terms. As well 
as publishers, it was suggested that co-ordi-
nated work with other stakeholders, including 
other funders and universities, could encour-
age greater consistency.
Discussion
The research presented here contributes to a 
wider set of interlocking issues relating to OA 
and research policy. These include:
• policy v. practice for OA;
• green v. gold routes to OA;
• costs v. beneﬁ ts of OA;
• direct v. indirect funding for OA;
• organizational v. sectoral action on OA;
• sectoral v. cross-sectoral action on OA.
On the ﬁ rst of these, it is clear that the devel-
opment of more directive funder policies 
with regard to OA (and other major issues) 
is becoming more common in the medical 
research area. This represents a shift away 
from traditional custom and practice which 
tended to take a less interventionist position. 
Increasingly, funder organizations of all sorts 
wish to ensure and demonstrate value from 
their expenditure and therefore expect grant-
holders to comply with certain conditions in 
areas such as disseminating research outputs. 
Funders can therefore be reasonably expected 
to monitor compliance with their policies 
(requiring researchers to report on their activi-
ties) and develop approaches to further incen-
tivize compliance (in order to improve compli-
ance levels). The extent to which funders can 
do so without imposing unnecessary burdens 
on researchers is, however, a moot point and 
one on which respondents reﬂ ected in their 
comments. It is an important area for ongoing 
consideration in policy development. Equally 
important are practical issues associated with 
the administration of OA, such as business 
process design for APC payments, arrange-
ments for co-funding APCs and tracking 
activity. All of these require further work.
One speciﬁ c area of policy development 
with regard to OA reﬂ ected in the responses 
of participants is the green v. gold debate. This 
debate has been heightened in the UK, and 
internationally, by the Finch Report and sub-
sequent RCUK policy development which sig-
nalled a preference for Gold. The biomedical 
discipline has tended to favour gold rather than 
green to date in any case,14 although most of 
the policies reported in this study allow either, 
permitting no more than a six-month embargo 
period. It is important to note, however, that 
OA journal publishing and repository develop-
ment are not necessarily mutually exclusive 
OA models (despite the sometimes polar-
ized debate). Combined with an adoption of 
charged-for gold OA, large-scale disciplinary 
repositories (e.g. PubMed Central and Europe 
PMC) have been developed. A number of 
models of OA are emerging in practice which 
involve a combination of journals and reposito-
ries supported by various business and fund-
ing models.24 The increasingly successful OA 
scholarly communication system developed to 
support biomedical research is then not sus-
tained merely by APCs: a signiﬁ cant level of 
ongoing investment by biomedical research 
funders also goes into the maintenance of the 
large-scale biomedical repositories. The pre-
cise conﬁ guration of systems and processes in 
this and other disciplines, and the impact they 
will have on sustainable scholarly communica-
tion practices in the long term remains to be 
seen.
As well as the OA route (green or gold), 
the level of openness is an important policy 
issue. The extent to which OA materials are 
fully reusable and can therefore be processed 
in various ways (e.g. text mined) may vary 
signiﬁ cantly according to different licences. 
However, the absence of consideration of 
licences from responses seems to indicate this 
has not yet impacted on the current thinking 
of many charities. It might be expected that 
this will become more important as think-
ing on open access, and its consequences for 
research, develops.
One signiﬁ cant part of the question relat-
ing to the preferred OA model is that of cost. 
The data presented here showing APC costs 
as a proportion of overall research spend can 
potentially inform ongoing discussion. The 
proportions given are somewhat higher than 
those that have been quoted by advocates of 
gold OA in the past. They of course need test-
ing, and more (and more precise) data need 
to be assembled to add to the evidence base 
in the charity sector as well as others. One 
it is important 
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however, that 
OA journal 
publishing 
and repository 
development are 
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mutually 
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key question is that of APC levels and where 
these are likely to ‘settle’ as the APC market 
matures. The extent to which the market will 
tend to inﬂ ate APC prices is still uncertain 
and the role of institutions in leveraging their 
market power to keep APCs low remains to 
be seen.25
One other important consideration in rela-
tion to cost raised by this research is who pays. 
Although there is evidence that system-wide 
costs may be reduced by OA,26 the distribu-
tion of costs and beneﬁ ts in pure ﬁ nancial 
terms may not necessarily be evenly spread. 
There is concern amongst charities that they 
may experience additional costs without see-
ing commensurate savings elsewhere in their 
own budgets. Research institutions, on the 
other hand, may see an increase in costs to 
pay and administer APCs but in the long term 
are likely to see savings in periodicals sub-
scription budgets and related administration. 
Similarly, government funding agencies may 
see an increase in funds allocated to APCs 
but are likely to see reductions in funding for 
infrastructure such as library budgets (not-
withstanding transition costs). UK charities 
may experience rising costs but not see com-
mensurate savings. In wider OA implementa-
tion discussions, therefore, the overall position 
of stakeholders such as charities needs to be 
taken into account in structuring funding and 
directing funding streams. At the same time, 
there also perhaps needs to be a clear articu-
lation of the offsetting beneﬁ ts of OA for the 
different stakeholders (as well as the costs). 
Whilst many of these may be difﬁ cult to quan-
tify, they may nevertheless be signiﬁ cant, as 
some of the participants in this research indi-
cated. More work is required in order to dem-
onstrate beneﬁ ts against potentially increasing 
costs.
One speciﬁ c aspect of this debate is the 
question of direct v. indirect funding, an issue 
that was clearly considered to be important 
by respondents. In a sector which does not 
fund indirect costs, it may be easy to see the 
view that APCs should be deﬁ ned as indirect 
costs as a ‘get out’. However, the issue does, 
of course, relate to the question of principle 
of what is core to the mission of charities and 
therefore what charitable funding can legiti-
mately support. The in-principle question of 
whether the costs of publication are part of 
the costs of research itself remains important, 
and one around which there is considerable 
uncertainty. However, in practice, the direct 
v. indirect question may need to be addressed 
in a more nuanced way than a simple ‘either-
or’ argument. In the multi-funder, collabora-
tive research environment of UK biomedical 
research, where many stakeholders (funders, 
universities, researchers, health service pro-
viders) beneﬁ t from OA, alternative ways of 
determining how costs may be covered should 
perhaps be investigated.
The issue of direct v. indirect funding is one 
that needs to be addressed at a sectoral level 
by all medical research charities in liaison with 
government and others. This is an illustration 
of the importance of sector-wide action, where 
organizations such as the AMRC can provide 
a single voice for medical charities. The extent 
to which developments discussed in this paper 
can be taken forward through co-ordinated 
action is an important one for ongoing discus-
sion. This will partly depend on the capacity 
of individual organizations (which vary signiﬁ -
cantly amongst AMRC members) and partly 
on the extent to which a consensual position 
can be found throughout the sector enabling 
co-ordinated action.
In some cases, co-ordination needs to occur 
at a higher level, across sectors. Some activ-
ity, e.g. around OA policy, would beneﬁ t from 
research funders across sectors co- ordinating 
activity in various ways, including, for exam-
ple, policy development, and compliance 
monitoring. Also, establishing greater consis-
tency between OA policies between funders 
and institutions as well as agreeing operational 
approaches to issues such as co-funding APCs 
are certainly required. Such activity could 
also usefully happen internationally as well as 
cross-sectorally.
Conclusions
This research makes clear that many medi-
cal research charities consider OA to be an 
important current policy issue. Amongst 
respondents, there was considerable stated 
support for the principles of OA and little 
stated opposition. OA is clearly increasingly 
becoming an accepted part of research com-
munication. Some organizations already have 
OA policies and funding arrangements in 
there is concern 
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charities that 
they may 
experience 
additional costs 
without seeing 
commensurate 
savings 
elsewhere in 
their own 
budgets
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place and see OA as a way of furthering their 
mission. Other charities are currently under-
going changes. However, a large number (par-
ticularly, small organizations) are only now 
beginning to address the issues and are uncer-
tain about how best to do so. Concerns were 
expressed about the resource implications, 
with organizations feeling OA will create 
new ﬁ nancial costs, especially around funding 
APCs. Provisional data presented here does 
indicate the proportion of APC expenditure 
of total research spend may be higher for at 
least some organizations than has previously 
been assumed. Concerns have also been raised 
in relation to administration costs and the 
requirement for new expertise in organizations 
to support OA.
However, it is clear that at present too 
little is known about the details of publishing 
activity, potential costs and other key issues. 
Currently, data in these areas is being recorded 
inconsistently across different organizations. 
There is a need to make data gathering more 
consistent and sharing of such data, and 
other information, more systematic in order 
to inform policy discussions and to enable 
tracking of developments. Where appropriate, 
organizations such as AMRC, and perhaps the 
individual larger charities, can co-ordinate 
and lead activities, to share best practice and 
provide targeted advice and support. There is 
also potential for co-ordinated action in the 
sector in order to create beneﬁ ts for individual 
organizations as well as the sector as a whole. 
Cross-sectoral and international collaboration 
and co-ordination are also necessary to ensure 
that beneﬁ ts are maximized for the research 
community in general. The challenge now is 
not just to deliver open access but to do so in 
an optimal way.
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